MedTrace Logo

Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and in an Acute Stressful Situation (TSST - Trier Social Stress Test): A Randomized, Double-blind, Placebo-controlled Trial)

NCT02257801 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-01-22

No results posted yet for this study

Summary

The purpose of this study is to study effects of a four months lutein supplementation (in form of a lutein fortified nutritional beverage) on general learning and memory performance as well as on acute stress-induced changes in learning and memory performance in chronically stressed males and females using 2 different lutein doses in comparison to a placebo.

Conditions

  • Healthy But Chronically Stressed

Interventions

DIETARY_SUPPLEMENT

Nutritional beverage fortified with 6mg lutein/day

2 beverages (each containing 3mg lutein) per day (total of 6mg lutein/day) for a total of 4 months

DIETARY_SUPPLEMENT

Nutritional beverage fortified with 12mg lutein/day

2 beverages (each containing 6mg lutein) per day (total 12mg lutein/day) for a total of 4 months

DIETARY_SUPPLEMENT

Nutritional beverage fortified with 12mg lutein/day

2 beverages (each containing 0mg lutein) per day (total 0mg lutein/day) for a total of 4 months

Sponsors & Collaborators

  • Abbott Nutrition

    collaborator INDUSTRY

  • DSM Nutritional Products, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Clemens, MD · DAaCRO GmbH

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02257801 on ClinicalTrials.gov